Report Content
Chapter 1 Methodology
1.1 Methodology & Scope
1.2 Market definition
1.3 Base estimates & calculations
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Companion animal vaccines industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Vaccine type trends
2.5 Animal type trends
2.6 Route of administration trends
2.7 Distribution channel trends
Chapter 3 Companion Animal Vaccines Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of pet adoption
3.2.1.2 Rising prevalence of zoonotic diseases
3.2.1.3 Growing awareness about companion animal vaccination
3.2.1.4 Increasing government initiatives for companion animal vaccination
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of vaccine development
3.2.2.2 Stringent regulatory scenario for vaccine development
3.3 Growth potential analysis
3.3.1 By vaccine type
3.3.2 By animal type
3.3.3 By route of administration
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Technological advancements
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 List of core & non core vaccines by animal type
3.7.1 Canine
3.7.2 Feline
3.7.3 Equine
3.7.4 Pet Avian
3.8 Pet diseases and action mechanism
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Companion Animal Vaccines Market Size and Forecast, By Vaccine Type (USD Million)
5.1 Key trends, by vaccine type
5.2 Live Attenuated
5.3 Inactivated
5.4 Recombinant
5.5 Others
Chapter 6 Companion Animal Vaccines Market Size and Forecast, By Animal Type (USD Million)
6.1 Key trends, by animal type
6.2 Canine
6.3 Feline
6.4 Equine
6.5 Avian
Chapter 7 Companion Animal Vaccines Market Size and Forecast, By Route of Administration (USD Million)
7.1 Key trends, by route of administration
7.2 Injection Vaccines
7.3 Oral Vaccines
7.4 Spray Vaccines
Chapter 8 Companion Animal Vaccines Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Veterinary Hospital Pharmacies
8.3 Retail Pharmacy
8.4 Online Stores
Chapter 9 Companion Animal Vaccines Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 The Netherlands
9.3.9 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Malaysia
9.4.9 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.5.7 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Turkey
9.6.6 Iran
9.6.7 Rest of MEA
Chapter 10 Company Profiles
10.1 Elanco Animal Health Incorporated
10.2 Merck & Co., Inc
10.3 Boehringer Ingelheim International GmbH
10.4 Zoetis Inc.
10.5 Ceva Sante Animale
10.6 Durvet Inc.
10.7 Indian Immunologicals Ltd
10.8 Brilliant Bio Pharma
10.9 Bioveta, a.s.
10.10 Vetoquinol S.A.
10.11 Virbac
